Clinical Trials Directory

Trials / Completed

CompletedNCT01146210

Identification of de Novo Fanconi Anemia in Younger Patients With Newly Diagnosed Acute Myeloid Leukemia

Identification of de Novo Fanconi Anemia Patients Using FANCD2 Western Blots

Status
Completed
Phase
Study type
Observational
Enrollment
20 (actual)
Sponsor
Children's Oncology Group · Network
Sex
All
Age
21 Years
Healthy volunteers
Not accepted

Summary

This research study is studying identification of de novo Fanconi anemia in younger patients with newly diagnosed acute myeloid leukemia. Studying samples of tissue from patients with cancer in the laboratory may help doctors identify and learn more about biomarkers related to Fanconi anemia in patients with acute myeloid leukemia.

Detailed description

PRIMARY OBJECTIVES: I. Identify children with newly diagnosed acute myeloid leukemia (AML) treated on COG-2961 and COG-AAML03P1 who are at high risk of having de novo Fanconi anemia. II. Procure diagnostic samples from the COG AML Biology Repository and identify Fanconi anemia patients using western blot techniques. OUTLINE: Previously collected cryopreserved cells are analyzed via western blot to identify patients with Fanconi anemia.

Conditions

Interventions

TypeNameDescription
OTHERlaboratory biomarker analysisCorrelative studies

Timeline

Start date
2009-05-01
Primary completion
2016-05-01
Completion
2016-05-01
First posted
2010-06-17
Last updated
2016-05-17

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01146210. Inclusion in this directory is not an endorsement.